. | SMV . | Non-SMV . | |||||
---|---|---|---|---|---|---|---|
. | Pre-Survey . | Post-Survey . | 30-Day . | P . | Pre-Survey . | Post-Survey . | P . |
Immediate Gains | |||||||
Confidence* | |||||||
Ability to differentiate PK and PD profiles of basal insulins (%) | 24 (n = 142) | 68 (n = 143) | NA | <0.001 | 18 (n = 36) | 73 (n = 37) | <0.001 |
Ability to provide diabetes-related education in an SMV setting (%) | 28 (n = 138) | 67 (n = 142) | NA | <0.001 | NA | NA | NA |
Knowledge | |||||||
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) | 35 (n = 134) | 35 (n = 139) | NA | 0.970 | 31 (n = 36) | 50 (n = 36) | 0.012 |
PK and PD profiles of basal insulins (%) | 61 (n = 136) | 76 (n = 139) | NA | <0.001 | 49 (n = 35) | 64 (n = 36) | 0.066 |
Management of patients with T2DM using insulin (%) | 64 (n = 131) | 71 (n = 128) | 0.099 | 77 (n = 35) | 89 (n = 27) | 0.145 | |
Understanding SMV (%) | 18 (n = 128) | 59 (n = 135) | NA | <0.001 | NA | NA | NA |
Percent correct across three knowledge questions | NA | NA | NA | NA | 53 (n = 25) | 67 (n = 25) | 0.030 |
Percent correct across four knowledge questions | 45 (n = 99) | 61 (n = 99) | NA | <0.001 | NA | NA | NA |
Longer-Term Gains | |||||||
Confidence* | |||||||
Ability to differentiate PK and PD profiles of basal insulins (%) | 25 | NA | 44 | <0.001 | NA | NA | NA |
Ability to provide diabetes-related education in an SMV setting (%) | 32 (n = 62) | NA | 43 (n = 66) | <0.001 | NA | NA | NA |
Knowledge | |||||||
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) | 34 (n = 64) | NA | 52 (n = 64) | 0.003 | NA | NA | NA |
PK and PD profiles of basal insulins (%) | 66 (n = 65) | NA | 86 (n = 65) | 0.001 | NA | NA | NA |
Management of patients with T2DM using insulin (%) | 70 (n = 59) | NA | 74 (n = 66) | 0.403 | NA | NA | NA |
Understanding SMV (%) | 14 (n = 58) | NA | 41 (n = 66) | < 0.001 | NA | NA | NA |
Percent correct across four knowledge questions | 46 (n = 56) | NA | 63 (n = 66) | < 0.001 | NA | NA | NA |
. | SMV . | Non-SMV . | |||||
---|---|---|---|---|---|---|---|
. | Pre-Survey . | Post-Survey . | 30-Day . | P . | Pre-Survey . | Post-Survey . | P . |
Immediate Gains | |||||||
Confidence* | |||||||
Ability to differentiate PK and PD profiles of basal insulins (%) | 24 (n = 142) | 68 (n = 143) | NA | <0.001 | 18 (n = 36) | 73 (n = 37) | <0.001 |
Ability to provide diabetes-related education in an SMV setting (%) | 28 (n = 138) | 67 (n = 142) | NA | <0.001 | NA | NA | NA |
Knowledge | |||||||
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) | 35 (n = 134) | 35 (n = 139) | NA | 0.970 | 31 (n = 36) | 50 (n = 36) | 0.012 |
PK and PD profiles of basal insulins (%) | 61 (n = 136) | 76 (n = 139) | NA | <0.001 | 49 (n = 35) | 64 (n = 36) | 0.066 |
Management of patients with T2DM using insulin (%) | 64 (n = 131) | 71 (n = 128) | 0.099 | 77 (n = 35) | 89 (n = 27) | 0.145 | |
Understanding SMV (%) | 18 (n = 128) | 59 (n = 135) | NA | <0.001 | NA | NA | NA |
Percent correct across three knowledge questions | NA | NA | NA | NA | 53 (n = 25) | 67 (n = 25) | 0.030 |
Percent correct across four knowledge questions | 45 (n = 99) | 61 (n = 99) | NA | <0.001 | NA | NA | NA |
Longer-Term Gains | |||||||
Confidence* | |||||||
Ability to differentiate PK and PD profiles of basal insulins (%) | 25 | NA | 44 | <0.001 | NA | NA | NA |
Ability to provide diabetes-related education in an SMV setting (%) | 32 (n = 62) | NA | 43 (n = 66) | <0.001 | NA | NA | NA |
Knowledge | |||||||
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) | 34 (n = 64) | NA | 52 (n = 64) | 0.003 | NA | NA | NA |
PK and PD profiles of basal insulins (%) | 66 (n = 65) | NA | 86 (n = 65) | 0.001 | NA | NA | NA |
Management of patients with T2DM using insulin (%) | 70 (n = 59) | NA | 74 (n = 66) | 0.403 | NA | NA | NA |
Understanding SMV (%) | 14 (n = 58) | NA | 41 (n = 66) | < 0.001 | NA | NA | NA |
Percent correct across four knowledge questions | 46 (n = 56) | NA | 63 (n = 66) | < 0.001 | NA | NA | NA |
Extremely and moderately confident.
AACE, American Association of Clinical Endocrinologists; ADA, American Diabetes Association; PD, pharmacodynamic; PK, pharmacokinetic; T2DM, type 2 diabetes mellitus.